BREAKING: NAFDAC Approves 2 New COVID-19 Vaccines for Nigeria, Speaks on Risks, Benefits

BREAKING: NAFDAC Approves 2 New COVID-19 Vaccines for Nigeria, Speaks on Risks, Benefits

  • Two new COVID-19 vaccines, Moderna and Sputnik, were approved by NAFDAC on Thursday, July 15
  • NAFDAC's director-general, Moji Adeyeye, disclosed that the approval was given after the agency carried out independent research
  • Adeyeye added that the drugs at the moment have not been approved for use by the World Health Organisation

PAY ATTENTION: Join Legit.ng Telegram channel! Never miss important updates!

Abuja - After much consideration and research, the National Agency for Food, Drug Administration and Control (NAFDAC) has approved Moderna and Sputnik COVID-19 vaccines in Nigeria.

Professor Moji Adeyeye, NAFDAC's director-general, announced the approval on Thursday, July 15, during a press conference in Abuja, Channels TV reports.

Professor Moji Adeyeye in a news conference
NAFDAC said that despite the risks involved the vaccines are good for use (Photo: NAFDAC)
Source: Facebook

Professor Adeyeye explained that the decision of the agency came after it realised that the benefits of using the vaccines outweigh the risks, although they are yet to be approved by the World Health Organisation (WHO), The Nation also reported.

Read also

Good news: Nigerian govt to receive 41 million COVID-19 vaccines as third wave begins

FG to receive 41 million COVID-19 vaccines as third wave begins

Meanwhile, the federal government on Tuesday, July 13, said Nigeria was set to receive 41,282,770 doses of COVID-19 vaccines by the end of September 2021.

The announcement was made by the executive director of the National Primary Health Care Development Agency (NPHCDA), Faisal Shuaib, at the agency's weekly press briefing attended by Legit.ng reporter.

Speaking at the briefing Shuaib said the doses of vaccines expected in the country include the Oxford-AstraZeneca vaccines, Pfizer-Bio-N Tech/Moderna and Johnson & Johnson products.

PAY ATTENTION: Install our latest app for Android, read the best news on Nigeria’s #1 news app

Shuaib said the Oxford AstraZeneca and Pfizer vaccines are expected in the country through efforts of the COVID-19 Vaccines Global Assess Facility (COVAX) while the Johnson & Johnson vaccines was expected from the African Union Commission.

Read also

Nigerian government reacts as medical worker threaten to embark on strike

He said the government had already received communication for the delivery of the vaccine shipments in the coming months.

According to him, Nigeria is expecting 3,924,000 doses of Oxford/AstraZeneca/Moderna by end of July or early August 2021; 3,930,910 doses of Pfizer-Bio-N Tech/Moderna COVID-19 vaccine in August from the COVAX facility donated by the United States government and 3,577,860 doses of Pfizer-Bio-N Tech/Moderna COVID-19 vaccine in Q3 from the COVAX facility.

Source: Legit.ng

Authors:
Onyirioha Nnamdi avatar

Onyirioha Nnamdi Onyirioha Nnamdi is a graduate of Literature and English Language at the University of Lagos. He is a Politics/Current Affairs Editor who writes on news and political topics for Legit.ng. He brings into his reporting a wealth of experience in creative and analytical writing. Nnamdi has a major interest in local and global politics. He has a professional certificate from Reuters and was awarded the editor with the best listicle for 2021. Contact: 08062988054, o.nnamdi@corp.legit.ng